Topiramate Tablet, Film Coated
Product Images NDC 70518-2001

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 70518-2001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7ea951b6 B020 481f 8acc 12fb7a3a69fd 01

7ea951b6 B020 481f 8acc 12fb7a3a69fd 01
Chemical structure of topiramate as depicted in the image, showing its molecular formula representation with various functional groups and stereochemistry indicated.*
FDA Label Image

7ea951b6 B020 481f 8acc 12fb7a3a69fd 02

7ea951b6 B020 481f 8acc 12fb7a3a69fd 02
A line graph showing cumulative rates for time to first seizure over a period of 500 days. It compares two dosage groups of topiramate: 50 mg/day with a solid line and 400 mg/day with a dashed line, including sample sizes (N=234 and N=236 respectively). The graph shows lower cumulative seizure rates for the 400 mg/day group compared to the 50 mg/day group, with a significance value of P = 0.0002 indicated.*
FDA Label Image

7ea951b6 B020 481f 8acc 12fb7a3a69fd 03

7ea951b6 B020 481f 8acc 12fb7a3a69fd 03
A bar chart showing the change from baseline to double-blind phase in average monthly migraine period rate (+SE) across different doses of topiramate (50 mg/day, 100 mg/day, 200 mg/day) compared to placebo. It includes data from two studies (Study 11 and Study 12) with sample sizes indicated for each group. Statistical significance is marked with asterisks for various doses.*
FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Topiramate 200 mg film-coated tablet label showing quantity of 30 tablets. Label includes NDC number 70518-2001-00, manufacturer information for Zydus Pharm, Pennington, NJ, and repackaging by RemedyRepack Inc., Indiana, PA. The label advises storage conditions and keeping medication out of reach of children.*
FDA Label Image

Mm2 (Topiramate 200mg 70518 2001 01)

Mm2 (Topiramate 200mg 70518 2001 01)
Topiramate 200 mg oral film-coated tablet label showing a quantity of 100 tablets. The label includes the manufacturer RemedyRepack Inc., with repackaging information and storage instructions. The label displays the NDC number 70518-2001-01 and directions to see the package insert for use details.*
FDA Label Image

Mm3 (Topiramate 200mg 70518 2001 02)

Mm3 (Topiramate 200mg 70518 2001 02)
Topiramate 200 mg oral tablet packaging label from RemedyRepack Inc. The label shows one tablet quantity, the NDC number 70518-2001-02, and manufacturer Zydus Pharm, Pennington, NJ. It includes storage instructions and a note to see the package insert for directions. A QR code and repackaging information are also visible.*
FDA Label Image

Mm4 (Topiramate 200mg 70518 2001 03)

Mm4 (Topiramate 200mg 70518 2001 03)
Topiramate 200 mg film-coated tablets in a bottle label format by RemedyRepack Inc. The label shows a quantity of 30 tablets and includes NDC 70518-2001-03. It lists the manufacturer as Zydus Pharm, Pennington, NJ, and advises storage at 20-25°C. Directions refer to the package insert.*
FDA Label Image

Mm5 (Topiramate 200mg 70518 2001 04)

Mm5 (Topiramate 200mg 70518 2001 04)
Topiramate 200 mg oral tablet repackaged by RemedyRepack Inc., Indiana. The label includes the NDC number 70518-2001-04, manufacturer information (Zydus Pharm, Pennington, NJ), quantity of 1 tablet, and storage instructions at 20-25°C with permitted excursions. The label states RX only and advises to see package insert for directions.*
FDA Label Image

Topiramate 200mg 70518 2001 05

Topiramate 200mg 70518 2001 05
Topiramate 200 mg tablet label by RemedyRepack Inc. The label indicates a quantity of 60 tablets, with prescription use only. It includes manufacturer Zydus Pharm, Pennington, NJ, and storage instructions to keep at 20-25°C with allowable excursions. Additional data matrix code and repackaging information by RemedyRepack in Indiana, PA, are shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.